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Background: Chromosomal abnormalities are common in embryos produced in vitro and cause implantation
failure, miscarriage, and serious medical problems in infants. Because preimplantation genetic screening (PGS) is
increasingly being used to detect aneuploidy in embryos with the purpose of improving implantation rates after
IVF (in vitro fertilization), we aimed to validate the usefulness of array CGH for the preimplantation genetic
screening (PGS) of embryos at the blastocyst stage of development.
Results: A total of 150 blastocysts were biopsied from couples undergoing IVF and analyzed using array CGH.
We found that 54.5% (73/134) of the blastocysts were euploid embryos, whereas 45.5% of the embryos (61/134)
had chromosomal abnormalities. Multiple chromosome abnormality was most frequently observed (34.4%), and
dual aneuploidy was observed in 26.2% of the embryos. Monosomy (21.3%) appeared more frequently than
trisomy (18%).
Conclusion: Chromosomal microarray analysis provided clinically significant cytogenetic information regarding the
frequency and variety of chromosomal abnormalities observed in embryos at the blastocyst stage, suggesting that
this is a useful tool for comprehensive aneuploidy screening in IVF.Background
During IVF procedures, a preimplantation genetic diag-
nosis (PGD) is used to eliminate embryos carrying ge-
netic diseases prior to implantation. The first application
of PGD was successfully performed for couples at risk
for transmitting recessive X-linked diseases to male off-
spring [1], whereby polymerase chain reaction (PCR)
was used to determine the sex of the embryos.
Unlike PCR methods, preimplantation genetic scree-
ning (PGS) aims to provide a means for identifying po-
tentially viable euploid embryos i.e., screening that may
improve pregnancy rates. PGS was first described by
Verlinsky et al. [2] and Munne et al. [3]. Although previ-
ous methods for embryo screening used fluorescence in
situ hybridization (FISH) to analyze chromosomes [4,5],
the FISH approach is limited because the technique is
unable to screen all chromosomes simultaneously. Con-
ventional comparative genomic hybridization (CGH) has* Correspondence: ceo@mgmed.com
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reproduction in any medium, provided the orbeen used to comprehensively screen for aneuploidy in
oocytes and embryos [6,7]. However, although useful for
selecting euploid embryos, the CGH protocol is not ge-
nerally used because it is time consuming and compli-
cated. At present, both array CGH (aCGH) and single
nucleotide polymorphism (SNP) arrays have been vali-
dated as accurate methods for producing comprehensive
analyses of chromosome in embryos that are compatible
with day-3 biopsies and day-5 replacements in a fresh
cycle [8-12]. The difference in mosaicism between em-
bryos at days 3 and 5 has led to a preference for biopsies
at the blastocyst stage [13,14].
Here, we describe the results of an embryo analysis
and the details of the chromosomal abnormalities found.Results
In total, we analyzed 150 blastocysts from 49 couples un-
dergoing IVF (Table 1). Amplification was not detected in
11 (7.3%) embryos, and noisy profile results were obtained
for 3.6% (5/139) of the embryos. Euploidy was found in
54.5% of the embryos (73/134), whereas chromosomal ab-
normalities were found in 45.5% (61/134) of the embryos.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.





Embryos without amplification 11
Embryos with noisy profile 5
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euploid embryos (n=61) are summarized in Table 2. The
type of chromosomal abnormality that was most fre-
quently observed was multiple chromosomal abnorma-
lity (34.4%), and the second most frequent was dual
chromosomal abnormality (26.2%). Monosomy (21.3%)
appeared more frequently than trisomy (18%). Examples
of array CGH profiles are shown in Figure 1.
The chromosomes that were most frequently detected
to have aneuploidy were, in order, 15, 22, 21, 16, and 18.
Chromosomes 4 and 12 were the least frequently found
to have aneuploidy.
Discussion
Preimplantation genetic screening for aneuploidy is in-
creasingly used to examine the chromosomes of em-
bryos from couples undergoing IVF [8-10,15,16]. The
purpose of PGS is to identify embryos that are free from
chromosomal abnormalities. The main indications for
PGS are maternal age, repeated implantation failure, and
repeated miscarriage. We examined 150 embryos from
49 couples with these indications.
As shown in Table 1, we successfully analyzed 89.3%
(134/150) of the embryos and found that 45.5% (61/134)
of the embryos contained abnormal chromosomes. Al-
though the array CGH method is robust and specific, we
observed some failure in amplification and a noisy pro-
file. Some cells containing degraded DNA or samples of
low quality resulting from apoptosis can be obtained
during the biopsy procedure, causing experimental error.Table 2 Chromosome abnormality analyzed
Aneuploid types Number (%)
Single chromosome loss 13 (21.3%)
Single chromosome gain 11 (18.0%)
Dual chromosomal abnormality 16 (26.2%)
Multiple chromosomal abnormality 21 (34.4%)The results showed excessive single chromosome loss
versus single chromosome gain (Table 2); frequent ab-
normalities in chromosomes 15, 22, 21, 16, and 18;
and rare aneuploidy in chromosomes 4 and 12, which
are similar to the results of previous reports [17-19].
Although the frequency of chromosomal abnormalities
varied, aneuploidy occurred in all of the 24 chromo-
somes (data not shown), suggesting that PGS is necessary
for selecting healthy embryos during IVF procedures.
Previous studies have shown the importance of scree-
ning embryos with improved pregnancy success as a
result [19].
In conclusion, array CGH is a useful technique for the
detection of chromosomal abnormalities during IVF pro-
cedures, as previously described [18]. However, embryo
cultures up to days 5 or 6 should be established before
performing array CGH experiments on blastocysts, and
further evidence is required to determine whether PGS
results in enhanced delivery rates[14].Methods
Patient materials
A total of 150 blastocysts were collected from 49 couples
who visited the clinic center to undergo IVF between
September 2011 and December 2012. All patient mate-
rials were obtained and evaluated with informed patient
consent and under approval from the Ethics Committees
of MGMED clinic center and Seoul Rachel Fertility
Center. All patients were provided with counseling re-
garding PGS using array CGH and signed an informed
consent prior to entering the study.Experimental procedures
The biopsied cells were washed in PBS and collected into
PCR tubes. Whole-genome amplification was performed
using a kit and following the manufacturer’s instructions
(Sigma-Aldrich, Saint Louis, MO).
Approximately 3 μg of amplified DNA was used in the
array CGH experiments, as described, with slight modifi-
cations [20]. Briefly, the amplified DNA was labeled with
Cy-3 and Cy-5 dCTP for 3 h using a random priming
method. The labeled DNA was purified, dissolved in
hybridization buffer, and hybridized overnight. The slides
were washed several times and dried as described [21].
Images of the slides were acquired with a GenePix4000B
dual-laser scanner (Axon Instruments, Union City, CA)






































Figure 1 Examples of array CGH results are shown. (A) Array result displaying a female cell with the loss of chromosome 22. (B) A male cell
with trisomy 21. (C) An XY cell showing two chromosomal abnormalities i.e., gain of chromosome 8 and loss of chromosome 14. (D) A male cell
with multiple chromosomal abnormalities - gain of chromosomes 3 and 15 and loss of chromosome 22. (E) A normal female cell. (F) A cultured
cell with a 2p duplication was used as a positive control.
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